Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

A UK proposal to relax criteria for offshore wind developers taking part in project auctions threatens to undermine ...

Britain's FTSE 100 held steady on Thursday, taking a breather from its recent rally as investors processed a wave of ...

European shares ended higher on Thursday, boosted by automakers and materials stocks, as investors digested a mixed set of ...